PAN-90806: Preliminary Phase I/II data

Preliminary data from stage 1 of the open-label, U.S. Phase I PAN-01-101 trial in 40 treatment-naive patients with wet AMD showed that all dose levels of once-daily topical PAN-90806 ophthalmic soluti...